Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 153
- News
Former Prime Minister’s Cannabis Company Delivers 170% Sales Boost
INTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter.
- Cultivation
Guernsey Issues Its First Medical Cannabis Cultivation Licence To 4C Labs With More Set To Follow
4C LABS has become the first and only company to be awarded a medical cannabis cultivation licence in Guernsey marking a major milestone for the Channel Islands’ cannabis industry.
- Opinion
26-Year-Old Dubliner Becomes Ireland’s First ‘Medical Cannabis Access Programme’ Patient
IRELAND now has its first patient through the state-approved Medical Cannabis Access Programme (MCAP) some four years after it was launched – but experts warn the scheme is still unfit for purpose.
- News
Danish Cultivator Completes New Facility Gearing Itself For ‘High-Volume Production’
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards profitability, despite reporting no sales and increasing losses in its third quarter.
- Opinion
Europe Just Months Away From ‘Recreational Cannabis Domino Effect’, Says Curaleaf Chief
CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in preparation for what it believes to be the imminent rise of recreational cannabis across Europe.
- CBD Market
With Its Stock In Free Fall CBD Firm Chill Brands Looks To Boost ‘Execution’ And ‘Investor Relations’
CHILL Brands Group, a retailer of CBD products in the US, UK and Europe, has seen some £180m wiped off its market value this year.
- CBD Market
Kanabo Aiming To Become Europe’s First Cannabis ‘Unicorn’
UK Market-listed cannabis business Kanabo is now generating its first revenues following the successful launch of its flagship VapePod product.
- Pharmaceutical
Cannabis Europa – ‘A Melting Pot Of Ideas And Conversations’ – Makes A Successful London Return
STEPHEN Murphy, co-founder and CEO of Prohibition Holdings, kicked-off Cannabis Europa 2021 in central London’s Banking Hall yesterday, welcoming delegates from across Europe and North America, Africa, Asia and Australia.
- News
Portuguese Firm Atann Helps De-Risk Supply Chain Market Entry With ‘One-Stop Shop’
ATANN, a Portuguese company founded in May last year, is poised to become the country’s first cannabis contract manufacturer.
- Medical
Cannabis Company’s Buy And Build Strategy Boosted By High Profile Investor Support
AFTER recently announcing billionaire investor Christian Angermayer had become its largest shareholder German cannabis company SynBiotic has secured a further €7m to fuel its rapid expansion plans.
- CBD Market
CBD Business Love Hemp To List On The London Stock Exchange Within The Next Few Months
LOVE Hemp Group informed its investors this week that its upcoming admission to the London Stock Exchange’s (LSE) is “imminent”.
- Pharmaceutical
UK Cannabis Company’s C-Suite Left ‘Shaking Their Heads’ In Disbelief At Company’s Poor Stock Performance
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than £20m wiped off its market capitalisation.
